Pendrell Corporation acquired 68.75% stake in Provitro Biosciences LLC for $16.6 million.
Pendrell Corporation (NasdaqGS:PCO) completed the acquisition of 68.75% stake in Provitro Biosciences LLC on February 21, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
150,000 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 139M | |
+17.34% | 465M | |
+1.10% | 335M | |
+90.00% | 168M | |
-12.98% | 143M | |
+164.26% | 107M | |
+32.81% | 97.67M | |
+89.58% | 64.69M |